2 months ago
BHVN
Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Biohaven LtdBHVN | +174.33% | $14.65 | $40.19 | 2023-01-03 - 2024-01-03 | Strong Buy |
Dyne Therapeutics IncDYN | +125.52% | $10.58 | $23.86 | 2023-08-08 - 2024-04-19 | Strong Buy |
Edgewise Therapeutics IncEWTX | +96.52% | $7.75 | $15.23 | 2023-06-29 - 2024-04-19 | Strong Buy |
Biohaven LtdBHVN | +96.13% | $19.88 | $38.99 | 2023-08-15 - 2024-04-19 | Strong Buy |
Cytokinetics IncCYTK | +92.02% | $35.20 | $67.59 | 2023-03-19 - 2024-03-19 | Strong Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Acadia Pharmaceuticals IncACAD | 4 | Strong Buy | $25.00 | +48.63% | Maintains | a month ago |
Neumora Therapeutics IncNMRA | 3 | Strong Buy | $22.00 | +116.11% | Maintains | a month ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $77.00 | +13.99% | Maintains | a month ago |
Agios Pharmaceuticals IncAGIO | 3 | Hold | $30.00 | +1.59% | Maintains | 2 months ago |
Biohaven LtdBHVN | 4 | Strong Buy | $56.00 | +43.63% | Maintains | 2 months ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $35.00 | +98.30% | Initiates Coverage On | 3 months ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $20.00 | +65.98% | Initiates Coverage On | 5 months ago |
Y Mabs Therapeutics IncYMAB | 5 | Strong Sell | $7.00 | -53.73% | Maintains | 8 months ago |
Dyne Therapeutics IncDYN | 2 | Strong Buy | $22.00 | -7.80% | Maintains | 8 months ago |
Edgewise Therapeutics IncEWTX | 6 | Strong Buy | $25.00 | +64.15% | Maintains | 10 months ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $55.00 | +37.91% | Maintains | a year ago |
Seres Therapeutics IncMCRB | 1 | Hold | $7.00 | +1,150.00% | Initiates Coverage On | a year ago |
Scholar Rock Holding CorpSRRK | 2 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $36.00 | N/A | Maintains | 2 years ago |
Orchard Therapeutics PLCORTX | 1 | Strong Buy | $150.00 | N/A | Assumes | 3 years ago |